全文获取类型
收费全文 | 2153篇 |
免费 | 106篇 |
国内免费 | 15篇 |
专业分类
耳鼻咽喉 | 50篇 |
儿科学 | 49篇 |
妇产科学 | 48篇 |
基础医学 | 206篇 |
口腔科学 | 88篇 |
临床医学 | 177篇 |
内科学 | 495篇 |
皮肤病学 | 31篇 |
神经病学 | 129篇 |
特种医学 | 43篇 |
外科学 | 390篇 |
综合类 | 60篇 |
一般理论 | 2篇 |
预防医学 | 115篇 |
眼科学 | 63篇 |
药学 | 164篇 |
中国医学 | 11篇 |
肿瘤学 | 153篇 |
出版年
2023年 | 18篇 |
2022年 | 45篇 |
2021年 | 86篇 |
2020年 | 47篇 |
2019年 | 65篇 |
2018年 | 89篇 |
2017年 | 57篇 |
2016年 | 69篇 |
2015年 | 75篇 |
2014年 | 83篇 |
2013年 | 102篇 |
2012年 | 167篇 |
2011年 | 160篇 |
2010年 | 89篇 |
2009年 | 70篇 |
2008年 | 142篇 |
2007年 | 120篇 |
2006年 | 110篇 |
2005年 | 129篇 |
2004年 | 103篇 |
2003年 | 95篇 |
2002年 | 84篇 |
2001年 | 33篇 |
2000年 | 14篇 |
1999年 | 24篇 |
1998年 | 12篇 |
1997年 | 9篇 |
1996年 | 10篇 |
1995年 | 12篇 |
1994年 | 13篇 |
1993年 | 4篇 |
1992年 | 10篇 |
1991年 | 4篇 |
1990年 | 10篇 |
1989年 | 6篇 |
1988年 | 9篇 |
1987年 | 8篇 |
1986年 | 8篇 |
1985年 | 4篇 |
1984年 | 6篇 |
1982年 | 8篇 |
1981年 | 8篇 |
1980年 | 6篇 |
1979年 | 5篇 |
1974年 | 4篇 |
1972年 | 3篇 |
1971年 | 5篇 |
1970年 | 8篇 |
1969年 | 4篇 |
1968年 | 4篇 |
排序方式: 共有2274条查询结果,搜索用时 15 毫秒
41.
Background Acute myocardial infarction (AMI) is a common cause of heart failure (HF), which can develop soon after AMI and may persist or resolve or develop late. HF after an MI is a major source of mortality. The cumulative incidence, prevalence and resolution of HF after MI in different age groups are poorly described. This study describes the natural history of HF after AMI according to age. Methods Patients with AMI during 1998 were identified from hospital records. HF was defined as treatment of symptoms and signs of HF with loop diuretics and was considered to have resolved if loop diuretic therapy could be stopped without recurrence of symptoms. Patients were cate- gorised into those aged 〈 65 years, 65-75 years, and 〉 75 years. Results Of 896 patients, 311,297 and 288 were aged 〈 65, 65-75 and 〉75 years and of whom 24%, 57% and 82% had died respectively by December 2005. Of these deaths, 24 (8%), 68 (23%) and 107 (37%) oc- curred during the index admission, many associated with acute HF. A further 37 (12%), 63 (21%) and 82 (29%) developed HF that persisted until discharge, of whom 15, 44 and 62 subsequently died. After discharge, 53 (24%), 55 (40%) and 37 (47%) patients developed I-IF for the first time, of whom 26%, 62% and 76% subsequently died. Death was preceded by the development of HF in 35 (70%), 93 (91%) and 107 (85%) in aged 〈 65 years, 65-75 years and 〉75 years, respectively. Conclusions The risk of developing HF and of dying after an MI in- creases progressively with age. Regardless of age, most deaths after a MI are preceded by the development of HF. 相似文献
42.
Gamal Shiha Nasser Mousa Reham Soliman Nabiel NNH Mikhail Mohamed Adel Elbasiony Mahmoud Khattab 《Journal of viral hepatitis》2020,27(7):671-679
Liver cirrhosis is an important risk factor for hepatocellular carcinoma. The reported annual incidence of HCC is about 3%‐8% in CHC cirrhotic patients. Based on the Cochrane systematic review, there was no clear evidence, on the long‐term clinical effects of DAAs in patients achieving SVR, as regard liver cirrhosis‐related HCC incidence. The aim of the study was to determine the incidence of HCC in chronic hepatitis C patients genotype IV with liver cirrhosis and advanced liver fibrosis after achieving SVR following DAA treatment in a prospective large cohort of HCV patients with long follow‐up. This was a prospective observational cohort study including 2372 CHC patients with advanced liver fibrosis or cirrhosis receiving DAA therapy in outpatient clinics at the Egyptian Liver Research Institute and Hospital since January 2015. Liver fibrosis was assessed using transient elastography. Abdominal ultrasonography and AFP measurement were done at baseline and follow‐up visits every 6 months, in addition to triphasic abdominal MSCT when needed. Patients were followed up after achieving SVR12 for at least 12 months. HCC developed in 109 cases during the follow‐up period (mean 23.60 ± 8.25 months). Overall HCC incidence was 2.338/100 PY, 95% CI = 1.942‐2.814. In patients with cirrhosis, the incidence of HCC was 2.917/100 PY, 95% CI = 2.407‐3.535, while in patients with advanced liver fibrosis the incidence of HCC was 0.664/100 PY, 95% CI = 0.333‐1.326. In conclusion, the incidence of HCC was reduced in chronic hepatitis C genotype 4 patients with liver cirrhosis (F4) and advanced hepatic fibrosis (F3) who achieved SVR following DAA therapy. 相似文献
43.
Francisco Leonardo Galastri Guilherme Moratti Gilberto Breno Boueri Affonso Leonardo Guedes Moreira Valle Priscila Mina Falsarella Adriano Mendes Caixeta Camila Antunes Lima Marcela Juliano Silva Lucas Lembran a Pinheiro Conrado Dias Pacheco Annicchino Baptistella M rcio Dias de Almeida Rodrigo Gobbo Garcia Nelson Wolosker Felipe Nasser 《World journal of hepatology》2020,12(7):399-405
BACKGROUND Percutaneous transluminal angioplasty and stenting represent an effective treatment for hepatic artery stenosis after liver transplantation. In the first year after stenting, approximately 22% of patients experience in-stent restenosis, increasing the risk of artery thrombosis and related complications, and 50% experience liver failure. Although angiography is an important tool for diagnosis and the planning of therapeutic interventions, it may raise doubts, especially in small-diameter arteries, and it provides low resolution rates compared with newer intravascular imaging methods, such as optical coherence tomography(OCT).CASE SUMMARY A 64-year-old male developed hepatic artery stenosis one year after orthotropic liver transplantation and was successfully treated with percutaneous transluminal angioplasty with stenting. Five months later, the Doppler ultrasound results indicated restenosis. Visceral arteriography confirmed hepatic artery tortuosity but was doubtful for significant in-stent restenosis(ISR) and intrahepatic flow reduction. To confirm ISR, identify the etiology and guide treatment, OCT was performed. OCT showed severe stenosis due to four mechanisms: Focal and partial stent fracture, late stent malapposition, in-stent neointimal hyperplasia, and neoatherosclerosis.CONCLUSION Intravascular diagnostic methods can be useful in evaluating cases in which initial angiography results are not sufficient to provide a proper diagnosis of significant stenosis, especially with regard to ISR. A wide range of diagnoses are provided by OCT, resulting in different treatment options. Interventional radiologists should consider intravascular diagnostic methods as additional tools for evaluating patients when visceral angiography results are unclear. 相似文献
44.
Development of homogenous metal matrix nanocomposites with uniform distribution of nanoreinforcement, preserved matrix nanostructure features, and improved properties, was possible by means of innovative processing techniques. In this work, Al-SiC nanocomposites were synthesized by mechanical milling and consolidated through spark plasma sintering. Field Emission Scanning Electron Microscope (FE-SEM) with Energy Dispersive X-ray Spectroscopy (EDS) facility was used for the characterization of the extent of SiC particles’ distribution in the mechanically milled powders and spark plasma sintered samples. The change of the matrix crystallite size and lattice strain during milling and sintering was followed through X-ray diffraction (XRD). The density and hardness of the developed materials were evaluated as function of SiC content at fixed sintering conditions using a densimeter and a digital microhardness tester, respectively. It was found that milling for 24 h led to uniform distribution of SiC nanoreinforcement, reduced particle size and crystallite size of the aluminum matrix, and increased lattice strain. The presence and amount of SiC reinforcement enhanced the milling effect. The uniform distribution of SiC achieved by mechanical milling was maintained in sintered samples. Sintering led to the increase in the crystallite size of the aluminum matrix; however, it remained less than 100 nm in the composite containing 10 wt.% SiC. Density and hardness of sintered nanocomposites were reported and compared with those published in the literature. 相似文献
45.
46.
Alkharfy KM Al-Daghri NM Al-Attas OS Alokail MS Mohammed AK Vinodson B Clerici M Kazmi U Hussain T Draz HM 《Endocrine journal》2012,59(3):253-263
Genetics plays a crucial role in the development of metabolic syndrome (MetS). Here we examined the association between endothelial nitric oxide synthase (eNOS) gene polymorphisms and MetS in a Saudi Arabian cohort to extend the understanding of the genetic basis of MetS in diverse ethnic populations. Anthropometric, clinical and biochemical parameters as well as genotyping for 894G>T, -786T>C variants of eNOS gene by PCR-RFLP and 4a/b by direct PCR were performed in 886 Saudi Arabians (477 MetS and 409 Non-MetS). The genotype distribution (TT, p=0.001; TC, p=0.001; TC+CC, p=0.001) and allele (T, p=0.007; C, p=0.007) frequency of the -786T>C SNP were significantly different between Non-MetS and MetS subjects which remained significant after Bonferroni correction. Moreover: 1) the GT and GT+TT genotypes of the 894G>T SNP were associated with elevated blood pressure (p=0.017, and p=0.022, respectively); 2) the ab variant of 4a/b polymorphism was associated with decreased HDL levels (p= 0.044); and 3) the TC+CC genotype and C allele of the -786T>C SNP were associated with increased fasting glucose levels (p=0.039, and p=0.028, respectively). Also, G-a-C was identified as the risk haplotype for MetS susceptibility (p=0.034). The results suggest a significant association of 894G>T, 4a/b and -786T>C polymorphisms with MetS and its components is present in an Arab population. A genetic predisposition to develop abnormal metabolic phenotypes, consistent with an increased prevalence of metabolic phenotypes can be detected in this ethnic group. 相似文献
47.
48.
Imayavaramban Lakshmanan Sanjib Chaudhary Raghupathy Vengoji Parthasarathy Seshacharyulu Satyanarayana Rachagani Joseph Carmicheal Rahat Jahan Pranita Atri Ramakanth ChirravuriVenkata Rohitesh Gupta Saravanakumar Marimuthu Naveenkumar Perumal Sanchita Rauth Sukhwinder Kaur Kavita Mallya Lynette M. Smith Subodh M. Lele Moorthy P. Ponnusamy Mohd W. Nasser Ravi Salgia Surinder K. Batra Apar Kishor Ganti 《Molecular oncology》2021,15(7):1866
49.
Megreya Ahmed M. Latzman Robert D. Al-Ahmadi Aisha M. Al-Dosari Nasser F. 《International journal of mental health and addiction》2022,20(5):2635-2651
International Journal of Mental Health and Addiction - The worldwide spread of the coronavirus disease (COVID-19), the absence of medical treatment and vaccination, the delayed onset of symptoms,... 相似文献
50.
Shiri Sherf Dagan Shira Zelber-Sagi Muriel Webb Andrei Keidar Asnat Raziel Nasser Sakran David Goitein Oren Shibolet 《Obesity surgery》2016,26(9):2119-2126